Analytical validation of a novel bioassay for thyroid-stimulating immunoglobulin

BackgroundA novel and rapid cell-based bioassay, Turbo TSI, for measurement of thyroid-stimulating immunoglobulins (TSI) was recently reported. An assessment of the analytical performance of this TSI bioassay is described herein.MethodsThawed cells from Turbo TSI kits were treated with different con...

Full description

Saved in:
Bibliographic Details
Main Authors: Paul D. Olivo, Hannah Kim, Lynn Miao, Jeffery A. Houtz, George J. Kahaly
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1468768/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850085804608585728
author Paul D. Olivo
Hannah Kim
Lynn Miao
Jeffery A. Houtz
George J. Kahaly
author_facet Paul D. Olivo
Hannah Kim
Lynn Miao
Jeffery A. Houtz
George J. Kahaly
author_sort Paul D. Olivo
collection DOAJ
description BackgroundA novel and rapid cell-based bioassay, Turbo TSI, for measurement of thyroid-stimulating immunoglobulins (TSI) was recently reported. An assessment of the analytical performance of this TSI bioassay is described herein.MethodsThawed cells from Turbo TSI kits were treated with different concentrations of a World Health Organization (WHO) international standard (IS) TSI-positive serum. TSI was measured as a function of luciferase activity measured as relative light units (RLU) and converted into international units per liter (IU/L). Analytical performance studies were performed on numerous samples, over multiple days, by two users at two sites.ResultsThe limit of blank, limit of detection and limit of quantitation were determined to be 0.007 IU/L, 0.014 IU/L, and 0.021 IU/L, respectively. Receiver operator characteristics (ROC) analysis determined the cut-off to be 0.0241 IU/L with an area under the curve of 0.984. The linear range was shown to be from 0.015 to 11.958 IU/L. The intra-laboratory precision was ≤15%CV. The overall reproducibility of the assay was ≤20%CV for five concentrations (0.06 to 5.16 IU/L). Interference and cross reactivity studies with a variety of substances showed that the assay was robust. The Turbo TSI bioassay demonstrated 95.2% (95% CI 83.3-98.1) positive percent agreement and 94.8% (95% CI 90.9-97.1) negative percent agreement with an FDA-cleared bioassay (Thyretain® TSI) using serum from 295 patients with autoimmune thyroid disease.ConclusionsThe Turbo TSI bioassay exhibits excellent analytical performance and a high level of reproducibility. The performance compared well with Thyretain® TSI, an FDA-cleared TSI bioassay.
format Article
id doaj-art-e52cd38c8141414593cc60f3b271ef39
institution DOAJ
issn 1664-2392
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj-art-e52cd38c8141414593cc60f3b271ef392025-08-20T02:43:38ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-01-011510.3389/fendo.2024.14687681468768Analytical validation of a novel bioassay for thyroid-stimulating immunoglobulinPaul D. Olivo0Hannah Kim1Lynn Miao2Jeffery A. Houtz3George J. Kahaly4Department of Microbiology and Microbial Pathogenesis, Washington University Medical School, St. Louis, MO, United StatesQuidelOrtho Corporation, San Diego, CA, United StatesQuidelOrtho Corporation, San Diego, CA, United StatesQuidelOrtho Corporation, San Diego, CA, United StatesMolecular Thyroid Research Laboratory, Department of Medicine I, Johannes Gutenberg University (JGU) Medical Center, Mainz, GermanyBackgroundA novel and rapid cell-based bioassay, Turbo TSI, for measurement of thyroid-stimulating immunoglobulins (TSI) was recently reported. An assessment of the analytical performance of this TSI bioassay is described herein.MethodsThawed cells from Turbo TSI kits were treated with different concentrations of a World Health Organization (WHO) international standard (IS) TSI-positive serum. TSI was measured as a function of luciferase activity measured as relative light units (RLU) and converted into international units per liter (IU/L). Analytical performance studies were performed on numerous samples, over multiple days, by two users at two sites.ResultsThe limit of blank, limit of detection and limit of quantitation were determined to be 0.007 IU/L, 0.014 IU/L, and 0.021 IU/L, respectively. Receiver operator characteristics (ROC) analysis determined the cut-off to be 0.0241 IU/L with an area under the curve of 0.984. The linear range was shown to be from 0.015 to 11.958 IU/L. The intra-laboratory precision was ≤15%CV. The overall reproducibility of the assay was ≤20%CV for five concentrations (0.06 to 5.16 IU/L). Interference and cross reactivity studies with a variety of substances showed that the assay was robust. The Turbo TSI bioassay demonstrated 95.2% (95% CI 83.3-98.1) positive percent agreement and 94.8% (95% CI 90.9-97.1) negative percent agreement with an FDA-cleared bioassay (Thyretain® TSI) using serum from 295 patients with autoimmune thyroid disease.ConclusionsThe Turbo TSI bioassay exhibits excellent analytical performance and a high level of reproducibility. The performance compared well with Thyretain® TSI, an FDA-cleared TSI bioassay.https://www.frontiersin.org/articles/10.3389/fendo.2024.1468768/fullanalytical performancevalidationbioassaythyroid-stimulating receptor antibodythyroid-stimulating immunoglobulin
spellingShingle Paul D. Olivo
Hannah Kim
Lynn Miao
Jeffery A. Houtz
George J. Kahaly
Analytical validation of a novel bioassay for thyroid-stimulating immunoglobulin
Frontiers in Endocrinology
analytical performance
validation
bioassay
thyroid-stimulating receptor antibody
thyroid-stimulating immunoglobulin
title Analytical validation of a novel bioassay for thyroid-stimulating immunoglobulin
title_full Analytical validation of a novel bioassay for thyroid-stimulating immunoglobulin
title_fullStr Analytical validation of a novel bioassay for thyroid-stimulating immunoglobulin
title_full_unstemmed Analytical validation of a novel bioassay for thyroid-stimulating immunoglobulin
title_short Analytical validation of a novel bioassay for thyroid-stimulating immunoglobulin
title_sort analytical validation of a novel bioassay for thyroid stimulating immunoglobulin
topic analytical performance
validation
bioassay
thyroid-stimulating receptor antibody
thyroid-stimulating immunoglobulin
url https://www.frontiersin.org/articles/10.3389/fendo.2024.1468768/full
work_keys_str_mv AT pauldolivo analyticalvalidationofanovelbioassayforthyroidstimulatingimmunoglobulin
AT hannahkim analyticalvalidationofanovelbioassayforthyroidstimulatingimmunoglobulin
AT lynnmiao analyticalvalidationofanovelbioassayforthyroidstimulatingimmunoglobulin
AT jefferyahoutz analyticalvalidationofanovelbioassayforthyroidstimulatingimmunoglobulin
AT georgejkahaly analyticalvalidationofanovelbioassayforthyroidstimulatingimmunoglobulin